Steven G Gray Selected Research

LCRF-0004

1/2019

When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven G Gray Research Topics

Disease

31	Neoplasms (Cancer) 09/2023 - 03/2003
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 11/2009
16	Mesothelioma 04/2024 - 01/2012
14	Lung Neoplasms (Lung Cancer) 04/2021 - 09/2009
8	Malignant Mesothelioma 02/2022 - 05/2012
7	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 12/2012
7	Carcinogenesis 01/2019 - 08/2005
4	Rheumatoid Arthritis 04/2014 - 04/2006
4	Huntington Disease (Huntington's Disease) 08/2011 - 04/2006
3	Adenocarcinoma 04/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2018 - 03/2011
3	Inflammation (Inflammations) 03/2017 - 04/2006
2	Melanoma (Melanoma, Malignant) 01/2023 - 06/2011
2	Rare Diseases (Rare Disease) 05/2021 - 02/2020
2	Rheumatic Diseases (Rheumatism) 04/2014 - 03/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2006 - 07/2005
2	Multiple Sclerosis 04/2006 - 07/2005
2	Hepatoblastoma 03/2003 - 06/2002
1	Fibrosis (Cirrhosis) 02/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Residual Neoplasm 04/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2021
1	Liver Neoplasms (Liver Cancer) 03/2019
1	Stomach Neoplasms (Stomach Cancer) 03/2019
1	Pathologic Processes 12/2018
1	Hepatocellular Carcinoma (Hepatoma) 05/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2017
1	Cytokine Release Syndrome 03/2017

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 03/2011
9	Proteins (Proteins, Gene)FDA Link 09/2023 - 06/2002
9	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2012
9	Histone Deacetylases (Histone Deacetylase)IBA 03/2019 - 03/2003
5	AsbestosIBA 05/2021 - 01/2013
5	MicroRNAs (MicroRNA)IBA 04/2021 - 02/2015
4	Messenger RNA (mRNA)IBA 09/2023 - 01/2015
4	Untranslated RNA (Noncoding RNA)IBA 12/2021 - 12/2015
4	Circular RNAIBA 12/2021 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 01/2015
4	Histone Deacetylase InhibitorsIBA 01/2015 - 07/2005
3	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2018
3	ElementsIBA 03/2017 - 03/2013
3	CytokinesIBA 11/2016 - 01/2013
3	Carrier Proteins (Binding Protein)IBA 04/2006 - 04/2005
2	Immune Checkpoint InhibitorsIBA 01/2023 - 05/2021
2	Ribosomal Protein S6IBA 12/2022 - 12/2022
2	Oxidoreductases (Dehydrogenase)IBA 08/2022 - 02/2022
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2019
2	Bevacizumab (Avastin)FDA Link 01/2022 - 02/2015
2	ParaffinIBA 01/2022 - 01/2019
2	Pemetrexed (MTA)FDA Link 01/2022 - 03/2011
2	enzalutamideIBA 12/2021 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 02/2015
2	Neuropilin-1IBA 01/2020 - 02/2015
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 03/2018
2	Interleukin-23 (Interleukin 23)IBA 01/2013 - 01/2013
2	Gemcitabine FDA Link 12/2012 - 03/2011
2	Vorinostat FDA Link 05/2012 - 01/2012
2	Insulin ReceptorIBA 03/2011 - 09/2007
2	trichostatin A (A 300)IBA 04/2006 - 07/2005
1	NanodiamondsIBA 01/2023
1	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 01/2023
1	Caspase 3 (Caspase-3)IBA 01/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2023
1	BMS202IBA 01/2023
1	Acyl Coenzyme A (Acyl CoA)IBA 08/2022
1	EnzymesIBA 08/2022
1	CollagenIBA 02/2022
1	Estrogen ReceptorsIBA 01/2022
1	InterferonsIBA 05/2021
1	RetinoidsIBA 04/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2021
1	Vitamin A (Retinol)FDA LinkGeneric 04/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2021
1	JIB-04IBA 03/2021
1	Small Interfering RNA (siRNA)IBA 03/2021
1	Histone DemethylasesIBA 03/2021
1	LipidsIBA 03/2021
1	N- (1- (2,3- dioleyloxy)propyl)- N,N,N- trimethylammoniumIBA 03/2021
1	Lipid NanoparticlesIBA 03/2021
1	didodecyldimethylammoniumIBA 03/2021
1	EphA2 ReceptorIBA 03/2021
1	ranatachykinin CIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 10/2020
1	chloropyramineIBA 10/2020
1	MethyltransferasesIBA 01/2020
1	LCRF-0004IBA 01/2019
1	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 01/2019
1	Arginine (L-Arginine)FDA Link 12/2018
1	Peptides (Polypeptides)IBA 12/2018
1	resminostatIBA 05/2018
1	napabucasinIBA 01/2018
1	Disulfiram (Antabuse)FDA Link 09/2017
1	C.I. Solvent Yellow 56 (DEAB)IBA 09/2017
1	AcidsIBA 08/2017

Therapy/Procedure

22	Therapeutics 01/2023 - 03/2003
8	Immunotherapy 04/2024 - 11/2016
8	Drug Therapy (Chemotherapy) 02/2022 - 03/2011
2	Castration 12/2021 - 01/2019
1	Salvage Therapy 02/2020